Combination therapy consisting of gemcitabine, docetaxel and carboplatin as a second-line chemotherapy for patients with MVAC-treated metastatic urothelial carcinoma
From 2001 to 2006, 11 patients with MVAC-treated metastatic urothelial carcinoma received as a second-line therapy GDC therapy consisting of gemcitabine (1,000 mg/m2) on day land 8, docetaxel (80 mg/m2) on day 1 and carboplatin (AUC 5) on day 1 in each 21-day cycle. The 11 patients received a total...
| Publié dans: | Hinyokika kiyo. Acta urologica Japonica. - 1962. - 54(2008), 9 vom: 23. Sept., Seite 581-5 |
|---|---|
| Auteur principal: | |
| Autres auteurs: | , , , , , , , , |
| Format: | Article |
| Langue: | Japanese |
| Publié: |
2008
|
| Accès à la collection: | Hinyokika kiyo. Acta urologica Japonica |
| Sujets: | Journal Article Taxoids Deoxycytidine 0W860991D6 Docetaxel 15H5577CQD Vinblastine 5V9KLZ54CY Doxorubicin 80168379AG plus... |